These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
3. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
4. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Feldman S; Andrew M; Norris M; McIntyre B; Iyer R Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893 [TBL] [Abstract][Full Text] [Related]
5. [Responses to triple viral and tetanus vaccination in HIV-infected children]. Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078 [TBL] [Abstract][Full Text] [Related]
6. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned? Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462 [No Abstract] [Full Text] [Related]
7. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium. Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877 [TBL] [Abstract][Full Text] [Related]
8. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077 [TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260 [TBL] [Abstract][Full Text] [Related]
10. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T; Baer M; Willems P Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879 [TBL] [Abstract][Full Text] [Related]
12. Gender differences in the reactogenicity of measles-mumps-rubella vaccine. Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264 [TBL] [Abstract][Full Text] [Related]
13. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age. Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661 [TBL] [Abstract][Full Text] [Related]
14. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100 [TBL] [Abstract][Full Text] [Related]
15. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis. Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Borte S; Liebert UG; Borte M; Sack U Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187 [TBL] [Abstract][Full Text] [Related]
17. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Poland GA Vaccine; 2007 Apr; 25(16):3090-100. PubMed ID: 17280755 [TBL] [Abstract][Full Text] [Related]